I am getting the eerie feeling that they are using acquisitions for opex.
Many disparities or things to ponder about
-
How come they acquired 4 LATAM partners and it is not in Cash flow from investing at all. What is this cash flow from financing increase? Why is it so large? What are they financing?
-
Their joint venture in China seems to be with hainan Jointown pharma that is based in Wuhan (of all places). Seems like some rigged company. If you are doing a joint venture, why would you want to do with an unknown company and not a market leader in China? funnily, the jointown pharma website is also not opening
-
Also they seeming started e-commerce sales in LATAM but the website could not be traced. Does anyone have the link to the e-commerce site?
Could it be possible that the company that an ace investor referred to in South India, where the promoter’s son is abroad and bills invoices to the dad is this one?
Looks like low P/E has most of the junk in the market.
I am starting to get an eerie feeling about this company now. Planning to exit. Thanks to the forum for helping in diving deeper